Actively Recruiting

Phase 1
Age: 16Years - 75Years
All Genders
NCT06808295

Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients

Led by Research Institute of Ophthalmology, Egypt · Updated on 2025-02-05

24

Participants Needed

1

Research Sites

54 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative

CONDITIONS

Official Title

Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients

Who Can Participate

Age: 16Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients of both sexes aged 16 to 75 years
  • ASA physical status classification I to III
Not Eligible

You will not qualify if you...

  • Pediatric patients
  • ASA physical status classification greater than III

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Research Institute of Ophthalmolgy

Giza, Egypt

Actively Recruiting

Loading map...

Research Team

D

Dina Moustafa Mohamed Ali, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here